An international journal to further the chemical sciences
Impact Factor 2.562 (Partial)
Paper

The synthesis of non-steroidal anti-inflammatory drug (NSAID)–lantadene prodrugs as novel lung adenocarcinoma inhibitors via the inhibition of cyclooxygenase-2 (COX-2), cyclin D1 and TNF-α-induced NF-κB activation

Show Affiliations
Hide Affiliations
*
Corresponding authors
a
Department of Pharmacy, Jaypee University of Information Technology, Waknaghat-173234, India
E-mail: lantadene@hotmail.com;
Fax: +91-1792-245362 ;
Tel: +91-1792-239407
b
Cancer Research Initiative Foundation, Drug Discovery Laboratory, 12A Jalan TP5, Taman Perindustrian UEP, 47600 Subang Jaya, Malaysia
RSC Adv., 2014,4, 19283-19293

DOI: 10.1039/C4RA00280F
Received 11 Jan 2014, Accepted 06 Mar 2014
First published online 06 Mar 2014
| | | | | | More
Please wait while Download options loads
Download Citation
 
 

Supplementary Info